Mark Hertzberg
Overview
Explore the profile of Mark Hertzberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
2070
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu B, Reagan P, Sehn L, Sharman J, Hertzberg M, Zhang H, et al.
Blood Adv
. 2025 Mar;
PMID: 40085955
In the phase 3 POLARIX study, polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) improved progression-free survival (PFS) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with...
2.
Abramson J, Ku M, Hertzberg M, Huang H, Fox C, Zhang H, et al.
Lancet
. 2024 Nov;
404(10466):1940-1954.
PMID: 39550172
Background: Glofitamab monotherapy induces durable remission in patients with relapsed or refractory diffuse large B-cell lymphoma after two or more previous therapies, but has not previously been assessed as a...
3.
Tobin J, Hapgood G, Johnston A, Cheah C, Lee S, Trotman J, et al.
Intern Med J
. 2024 Aug;
54(8):1384-1395.
PMID: 39099075
Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma subtype, accounting for 15-20% of all lymphoma diagnoses. Although typically slow-growing and responsive to frontline therapies, advanced-stage FL remains incurable...
4.
Shadman M, Ahn K, Kaur M, Lekakis L, Beitinjaneh A, Iqbal M, et al.
Blood Cancer J
. 2024 Jul;
14(1):108.
PMID: 38977682
In patients with relapsed DLBCL in complete remission (CR), autologous hematopoietic cell transplantation (auto-HCT) and CAR-T therapy are both effective, but it is unknown which modality provides superior outcomes. We...
5.
Borchmann P, Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, et al.
Lancet
. 2024 Jul;
404(10450):341-352.
PMID: 38971175
Background: Intensified systemic chemotherapy has the highest primary cure rate for advanced-stage, classical Hodgkin lymphoma but this comes with a cost of severe and potentially life long, persisting toxicities. With...
6.
Tiong I, Wall M, Bajel A, Kalro A, Fleming S, Roberts A, et al.
Blood Cancer J
. 2024 Mar;
14(1):54.
PMID: 38531863
Despite an increasing desire to use historical cohorts as "synthetic" controls for new drug evaluation, limited data exist regarding the comparability of real-world outcomes to those in clinical trials. Governmental...
7.
Odutola M, van Leeuwen M, Bruinsma F, Turner J, Hertzberg M, Seymour J, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Oct;
33(1):106-116.
PMID: 37831120
Background: Epidemiologic evidence suggests an inverse association between sun exposure and follicular lymphoma risk. Methods: We conducted an Australian population-based family case-control study based on 666 cases and 459 controls...
8.
Flowers C, Matasar M, Herrera A, Hertzberg M, Assouline S, Demeter J, et al.
Haematologica
. 2023 Sep;
109(4):1194-1205.
PMID: 37767550
Follicular lymphoma (FL) is the most common type of indolent non-Hodgkin lymphoma. Despite treatment advances that have improved outcomes for patients with relapsed or refractory (R/R) FL, many patients still...
9.
Odutola M, van Leeuwen M, Bruinsma F, Benke G, Turner M, Trotman J, et al.
Occup Environ Med
. 2023 Sep;
80(10):599-602.
PMID: 37722828
Objectives: We aimed to examine the relationship between occupational exposure to extremely low-frequency magnetic fields (ELF-MFs) and follicular lymphoma (FL) risk. Methods: We conducted a family case-control study between 2011...
10.
McErlean G, Tapp C, Brice L, Gilroy N, Kabir M, Greenwood M, et al.
BMC Psychol
. 2023 Aug;
11(1):235.
PMID: 37587508
Aims: Given the increasing number of Hematopoietic Stem Cell Transplantations (HSCT) performed world-wide, the increasing likelihood of survival following HSCT, and the profound physical, psychosocial, and emotional impact of HSCT...